E-Clinical solutions are software & applications used for the management of clinical trials & clinical research in the biotechnology and pharmaceutical industry. The software helps to manage & maintain data, record data, and track deadlines.
Referring to the study, “Global E-Clinical solutions Market: Market Segments: By Product Type (CTMS, eCOA, Analytics, RTMS, eTMF, Safety, CDMS, EDC); By Delivery Mode (On-Demand, On-premise, Cloud-based; ByEnd-User (CROs, Hospitals, Pharma/Biopharma Companies); and Region – Analysis of Market Size, Share & Trends for 2014 – 2019 and Forecasts to 2030”. Some of the key companies operating in the Global E-Clinical Solutions Market are Bioclinica, Inc., Medidata Solutions, Inc, Omnicomm Systems, Inc., E-Clinical Solutions, LLC., Bio-Optronics, Inc., Merge Healthcare Incorporated, Oracle Corporation, CRF Health, Datatrak International, Inc., Parexel International Corporation, Maxisit Inc.
Based on product type, the E-Clinical solutions market is segmented as clinical data integration platforms, Electronic Trial Master File Systems (eTMF), Electronic Data Capture (EDC) & Clinical Data Management Systems (CDMS), clinical analytics platforms, Electronic Clinical Outcome Assessment Solutions (eCOA), Randomization & Trial Supply Management (RTMS), safety solutions, clinical trial management systems (CTMS) and others. CTMS segment dominates the global market owing to benefits such as elimination of reliance on manual processes, centralized end-to-end management of clinical trial activities, and maintenance of multiple databases, which cumulatively improve the efficiency of clinical trials. Based on delivery mode, the market is segmented as a licensed enterprise (on-premise) solutions, web-hosted (on-demand) solutions and cloud-based (SaaS) solutions. Based on the clinical trial phase, the market is segmented as phase 1 clinical trial, phase 2 clinical trials, phase 3 clinical trials, and phase 4 clinical trials. In addition, based on end-user, the market is segmented as medical device manufacturer, contract research organizations, pharmaceutical & biopharmaceutical companies, consulting service companies, academic research institutes, hospitals, and others.
The E-Clinical solutions market is driven by growth in adoption of novel software solutions in clinical research, followed by an increase in operational costs & regulatory requirements associated with clinical research studies, growth in adoption of e-clinical solutions for improved data standardization, rise in government funding & grants to support clinical trials, increase in customer base for e-clinical solutions and surge in research & development (R&D) expenditure by pharma-biotech companies. However, the dearth of skilled professionals for operating e-clinical solutions, high implementation costs associated with e-clinical solutions and limited awareness among the researchers related to the advantages of e-clinical solutions may impact the market. Moreover, the increase in outsourcing of clinical trial processes and rise in the shift from manual data interpretation to real-time data analysis during the clinical studies is a key opportunity for the market.
Based on geography, the North-American region holds major share in the global E-Clinical solutions market owing to a rise in expenditure on R&D by pharmaceutical and biotechnology companies in the region. The Asian-pacific and European regions are estimated to witness a higher growth rate due to an increase in clinical trial outsourcing coupled with rising in a number of trials in countries such as China and India over the forecast period. It is anticipated that the future of the global market will be bright as a result of growth in technological advancements such as Wi-Fi connectivity & electronic data capture and amplification of IT budgets for drug production during the forecast period.
For More Information on the Research Report, refer to below links: -
Ankur Gupta, Head Marketing & Communications